Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Conference Sponsor
13
2018 - 08 - 21
点击次数:
Beijing Biocytogen Co., Ltd., an advanced biotechnology company located in Beijing’s Economic and Technological Development Zone, was founded in November 2009 by a team of scientists with extensive experience in developing animal models . Biocytogen’s goal is to become the leading supplier of gene modified animal models and services globally.
14
2018 - 08 - 21
点击次数:
MedGenesis Therapeutix Inc. (MedGenesis) is a privately-held Canadian biopharmaceutical company committed to developing and commercializing highly innovative treatments for patients with serious neurologic disease.MedGenesis' lead program, glial cell-line derived neurotrophic factor (GDNF), has recently completed Phase 2 clinical studies. The primary target indication for GDNF is Parkinson's disease, a progressive neurodegenerative disorder for which current treatment options are purely symptomatic. GDNF has the potential to become the world's first disease modifying therapy for Parkinson's disease. The program is the first to use MedGenesis' proprietary intermittent convection-enhanced delivery paradigm for targeted, local drug administration to the affected brain area.